Advancements in Endometriosis Treatment: Evaluating New Approaches to Managing and Treating Endometriosis, Including Hormone Therapy and Surgical Options

Abstract

Abstract
Endometriosis is a chronic gynecological condition that affects approximately 10% of reproductive-age women globally. The disorder is characterized by the growth of endometrial-like tissue outside the uterus, leading to inflammation, pelvic pain, and infertility. Standard treatments involve hormone therapy and surgical interventions, but both have limitations in terms of recurrence and side effects. This article evaluates the latest advancements in hormone therapy, including selective progesterone receptor modulators (SPRMs), gonadotropin-releasing hormone (GnRH) antagonists, and aromatase inhibitors (AIs), along with surgical innovations such as robotic-assisted laparoscopy and nerve-sparing techniques. A thorough review of the data highlights how these new treatments are transforming care, improving outcomes, and personalizing treatment plans for patients. Data analysis also includes a review of clinical outcomes, recurrence rates, and patient quality of life, supported by figures and charts.